| Product Code: ETC066720 | Publication Date: Jul 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Qatar Infectious Disease Point-of-care Testing Market was estimated at USD 145 Million in 2025 and is projected to reach USD 160 Million by 2032, growing at a CAGR of 1.4% from 2026 to 2032. This growth trajectory is driven by increasing incidences of infectious diseases and the urgent demand for rapid diagnostic solutions, especially in the wake of recent health crises. As healthcare systems in Qatar evolve, the focus on accessibility and timely patient care is expected to further bolster the adoption of point-of-care testing solutions.
This graph highlights how the Qatar Infectious Disease Point-of-care Testing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.3% | Increasing industrial infrastructure investments |
| 2022 | 5.5% | Government infrastructure modernization initiatives |
| 2023 | 5.7% | Government infrastructure modernization initiatives |
| 2024 | 0.4% | Increasing smart city development projects |
| 2025 | 0.5% | Expansion of commercial construction activities |
| 2026 | 1.2% | Increasing industrial infrastructure investments |
| 2027 | 1.1% | Increasing industrial infrastructure investments |
| 2028 | 1.8% | Rapid growth in telecom and data center sectors |
| 2029 | 2.5% | Government infrastructure modernization initiatives |
| 2030 | 2.3% | Increasing industrial automation investments |
| 2031 | 1.4% | Expansion of manufacturing activities |
| 2032 | 1.1% | Rapid growth in telecom and data center sectors |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
Recent developments in Qatar’s healthcare landscape highlight a marked increase in the reliance on point-of-care testing for infectious diseases. These tests are essential for addressing the urgent need for quick diagnostics, particularly in situations involving outbreaks of respiratory and gastrointestinal infections. The immediacy and convenience offered by POCT align well with the country's overarching healthcare objectives.
The drive towards enhancing healthcare accessibility is significant in shaping the infectious disease POCT market. With a growing emphasis on minimizing patient wait times and improving outcomes, the integration of POCT into routine clinical practice is expected to expand. This shift is not only about efficiency but also about transforming how healthcare is delivered in Qatar.
While the market is poised for growth, several key limitations hinder its full potential. One of the primary concerns involves ensuring the accuracy and reliability of point-of-care tests conducted outside traditional laboratory environments. It is essential for these tests to maintain high standards of quality to earn the trust of healthcare professionals and patients alike. Furthermore, there are regulatory challenges that may impede the rapid rollout of new testing technologies, necessitating thorough evaluations and certifications before market entry.
Emerging trends are significantly influencing the Qatar Infectious Disease Point-of-care Testing Market. Innovations in testing technologies, such as the use of digital health applications and enhanced connectivity features, are facilitating better data management and patient follow-up. Additionally, the integration of artificial intelligence in diagnostic tools is beginning to show promise, enabling faster and more accurate results. There’s also an increasing focus on personalized medicine, tailoring diagnostic processes to individual patient needs.
The landscape presents several lucrative opportunities for growth and investment in the Qatar infectious disease POCT market. The ongoing improvements in healthcare infrastructure and government backing for innovative health technologies signify a conducive environment for market players. Moreover, the rising trend of at-home testing, particularly for chronic and infectious diseases, offers a fresh avenue for expanding market reach. Collaborations between healthcare providers and technology developers could yield groundbreaking solutions, enhancing overall healthcare delivery.
The Qatari government has been proactive in supporting the healthcare sector, which includes the advancement of point-of-care testing technologies. Initiatives focusing on improving health infrastructure and increasing funding for healthcare research are encouraging innovation in diagnostics. Public health campaigns aimed at promoting awareness about infectious diseases also complement these efforts, creating a more informed public and fostering a supportive environment for the adoption of POCT.
Looking ahead to 2026-2032, the Qatar Infectious Disease Point-of-care Testing Market is likely to experience robust evolution. The ongoing digital transformation in healthcare suggests a future where POCT solutions will be even more integrated into routine care, facilitating immediate clinical decisions. The anticipated collaborations between public and private sectors are expected to drive innovation, enhance testing capabilities, and ensure that the diagnostic services meet the growing demands of the population.
Recent industry movements indicate a significant focus on expanding point-of-care testing capabilities in Qatar. New partnerships are forming between healthcare institutions and tech companies to enhance testing technologies, emphasizing faster turnaround times and improved accuracy. Furthermore, public health initiatives are increasingly integrating POCT into their strategies, aiming to strengthen national responses to infectious disease outbreaks.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Qatar Infectious Disease Point-of-care Testing Market Overview |
3.1 Qatar Country Macro Economic Indicators |
3.2 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, 2022 & 2032F |
3.3 Qatar Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 Qatar Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.6 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2022 & 2032F |
3.7 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Qatar Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Qatar |
4.2.2 Growing awareness and importance of early disease detection |
4.2.3 Technological advancements in point-of-care testing devices |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval process for point-of-care testing devices |
4.3.2 Limited healthcare infrastructure and resources in certain regions of Qatar |
4.3.3 High cost associated with point-of-care testing technologies |
5 Qatar Infectious Disease Point-of-care Testing Market Trends |
6 Qatar Infectious Disease Point-of-care Testing Market, By Types |
6.1 Qatar Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2022-2032F |
6.1.3 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2022-2032F |
6.1.4 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2022-2032F |
6.1.5 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2022-2032F |
6.1.6 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2022-2032F |
6.1.7 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
6.2 Qatar Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2022-2032F |
6.2.3 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2022-2032F |
6.2.4 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2022-2032F |
6.2.5 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2022-2032F |
6.3 Qatar Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2022-2032F |
6.3.3 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.4 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2022-2032F |
6.3.5 Qatar Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
7 Qatar Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 Qatar Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 Qatar Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 Qatar Infectious Disease Point-of-care Testing Market Key Performance Indicators |
8.1 Adoption rate of point-of-care testing in healthcare facilities |
8.2 Average turnaround time for test results |
8.3 Number of partnerships and collaborations between healthcare providers and point-of-care testing companies |
9 Qatar Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 Qatar Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.2 Qatar Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2022 & 2032F |
9.3 Qatar Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Qatar Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 Qatar Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2025 |
10.2 Qatar Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here